|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Quality Control and Quality Assurance in Pharmaceuticals |
| Authors Name: | Pritee Rajendra Supe , Prajakta Nilkanth Patane , Dr.Mrs.Rupali R.Bendgude. |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_214161
|
| Published Paper Id: | IJNRD2402257 |
| Published In: | Volume 9 Issue 2, February-2024 |
| DOI: | |
| Abstract: | A component of quality management, quality assurance is the process of giving assurance that the requirements for quality will be met. One way to characterize quality control is as a component of quality management that is concerned with meeting quality standards. Quality assurance (QA), quality control (QC), and good manufacturing practice (GMP) are critical considerations in the production, distribution, and marketing of pharmaceutical products. These processes ensure the products' identity, potency, purity, pharmacological safety, efficacy, and effectiveness. The phrases quality assurance, quality control, and good manufacturing practices are defined in most international regulatory regulations, including those from the USFDA, WHO, MHRA, TGA, and others. As low-quality medications can cause harm or even death to patients, it has been determined that having an adequate supply of vital medicines is essential to any nation's ability to provide a health care system. Even trace amounts of undesirable substances can affect a medication's safety and effectiveness. In addition to the inherent toxicity of some contaminants, impurities in pharmaceutical products can have detrimental effects on the stability and shelf-life of drugs, which gives rise to significant Concerns. Impurities are undesirable substances (organic, inorganic, and residual Solvents) that are added to or emerge during the manufacture of pharmaceutical and drug Products, or that persists with the active pharmaceutical ingredients (APIs) after they have aged. The most prevalent contaminants in all APIs are organic ones, which, even with appropriate handling, naturally integrate during the multi-step synthesis process. For project managers, quality assurance (QA) and internal control (QC) are becoming more and more crucial. Large expenses could arise from construction site malfunctions or defects. Large expenses could arise from construction site malfunctions or defects. Reconstruction is also necessary and facility operations are hampered, even with little flaws. The end effect is more expenses and longer delays. Internal control and quality assurance are crucial components of any building process that raise the project's standard and consistency. Due to recent significant changes and technological advancements, the need for QA and QC in building projects has expanded significantly technological breakthroughs and high user expectations. |
| Keywords: | Quality Control, Quality Assurance |
| Cite Article: | "Quality Control and Quality Assurance in Pharmaceuticals", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 2, page no.c507-c512, February-2024, Available :http://www.ijnrd.org/papers/IJNRD2402257.pdf |
| Downloads: | 000118766 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2402257 Registration ID: 214161 Published In: Volume 9 Issue 2, February-2024 DOI (Digital Object Identifier): Page No: c507-c512 Country: A/P-sade, Tal-Karmala, Dist-Solapur, Maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2402257 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2402257 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn